The National Cancer Institute (NCI) is offering this grant, the Sustained Support for Informatics Technologies (U24), to ensure ongoing development and sustainment of high-value informatics research resources. This NCI grant is for improving data acquisition, analysis, visualization, and interpretation throughout the cancer research continuum, encompassing biology, treatment, detection, prevention, and health disparities. It targets existing, widely-adopted tools, differing from new tool development grants. Applicants must justify the resource’s sustained benefit to cancer research and outline plans for assessing its value and fostering deep engagement with the community.
Opportunity ID: 338917
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CA-22-024 |
Funding Opportunity Title: | Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 24, 2022 |
Last Updated Date: | Mar 24, 2022 |
Original Closing Date for Applications: | Nov 17, 2022 |
Current Closing Date for Applications: | Nov 17, 2022 |
Archive Date: | Dec 23, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | County governments Native American tribal governments (Federally recognized) Small businesses Public housing authorities/Indian housing authorities For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Independent school districts Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high-value informatics research resources to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on sustaining operations and improving the user experience and availability of existing, widely-adopted informatics tools and resources. This is in contrast to early-stage and advanced development efforts to generate these tools and resources that are supported by companion ITCR FOAs. To be successful, the proposed sustainment plan must provide clear justification for why the research resource should be maintained and how it has benefitted and will continue to benefit the cancer research field. In addition, mechanisms for assessing and maximizing the value of the resource to researchers and supporting collaboration and deep engagement between the resource and the targeted research community should be described. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-024.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00272770 | May 14, 2022 | Nov 17, 2022 | View | |
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277614 | Oct 31, 2022 | Nov 17, 2022 | View |
Package 1
Mandatory forms
338917 RR_SF424_5_0-5.0.pdf
338917 PHS398_CoverPageSupplement_5_0-5.0.pdf
338917 RR_OtherProjectInfo_1_4-1.4.pdf
338917 PerformanceSite_4_0-4.0.pdf
338917 RR_KeyPersonExpanded_4_0-4.0.pdf
338917 RR_Budget_3_0-3.0.pdf
338917 PHS398_ResearchPlan_4_0-4.0.pdf
338917 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
338917 RR_SubawardBudget30_3_0-3.0.pdf
338917 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
338917 RR_SF424_5_0-5.0.pdf
338917 PHS398_CoverPageSupplement_5_0-5.0.pdf
338917 RR_OtherProjectInfo_1_4-1.4.pdf
338917 PerformanceSite_4_0-4.0.pdf
338917 RR_KeyPersonExpanded_4_0-4.0.pdf
338917 RR_Budget_3_0-3.0.pdf
338917 PHS398_ResearchPlan_5_0-5.0.pdf
338917 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
338917 RR_SubawardBudget30_3_0-3.0.pdf
338917 PHS_AssignmentRequestForm_3_0-3.0.pdf